Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00002189Phase 2Completed
A Phase 2 trial of paclitaxel in Kaposi sarcoma (KS), sponsored by Baker Norton Pharmaceutical. Status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00002189.